Understanding Tamoxifen-Regulated Recombination in B Cells
Author Information
Author(s): Buelow Ben, Scharenberg Andrew M., Fugmann Sebastian D.
Primary Institution: University of Washington, Seattle Children's Hospital Research Institute
Hypothesis
How do the parameters of tamoxifen-regulated mCrem recombination affect gene targeting in B cells?
Conclusion
The study reveals that high levels of mCrem expression lead to significant tamoxifen-independent Cre activity, while low expression allows for tight regulation.
Supporting Evidence
- High mCrem expression correlates with increased tamoxifen-independent activity.
- Low mCrem expression allows for tight regulation of Cre activity.
- Tamoxifen dose and exposure time significantly affect mCrem activity.
Takeaway
This study shows that if you have a lot of a certain protein, it can work even without its usual helper, but if you have just a little, it only works when the helper is around.
Methodology
The study used DT40 B lymphocytes to analyze the effects of mCrem expression levels and tamoxifen doses on gene recombination.
Potential Biases
Potential bias due to the specific conditions and constructs used in the experiments.
Limitations
The study primarily focuses on a specific cell line, which may limit the generalizability of the findings to other systems.
Participant Demographics
DT40 chicken B lymphocytes were used as the model system.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website